Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for IMYSF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for IMYSF and 80,000+ other tickers.
See exactly how IMYSF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IMYSF and 80,000+ other tickers.
Imerys S.A. is a global leader in delivering specialized mineral-based solutions across a broad spectrum of industries. The company's operations are structured into two primary segments: Performance Minerals and High Temperature Solutions. Within its extensive portfolio, Imerys offers additives for diverse applications including decorative, marine, facade, and can coatings, as well as for various rubber products such as tires, medical rubber, and cables, along with adhesives and sealants. It supplies essential minerals for both technical and traditional ceramics, encompassing products like…
Imerys S.A. (IMYSY) Q2 2026 Earnings Call Transcript
Imerys S.A. (IMYSY) Shareholder/Analyst Call Transcript
Imerys S.A. (IMYSY) Q1 2026 Earnings Call Transcript
Amrize (NYSE: AMRZ - Get Free Report) and Imerys (OTCMKTS:IMYSF - Get Free Report) are both basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings. Earnings and Valuation This table compares Amrize and Imerys"s
Imerys S.A. (IMYSY) Q4 2025 Earnings Call Transcript